Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Stuart K. Roberts(The Alfred Hospital), Amanda Nicoll(The Royal Melbourne Hospital), Vivek Ramachandra(Eastern Health), Gauri Mishra(Monash Medical Centre), John Lubel(Eastern Health), Paul Gow(The University of Melbourne), Eldho Paul(Monash Health), Siddharth Sood(The Royal Melbourne Hospital), Ammar Majeed(Monash University), Jim Koukounaras, Manfred Spanger(The Alfred Hospital), Anouk Dev(Monash Medical Centre), Ashu Jhamb(Services Australia), Adina Borsaru(Eastern Health), Marno Ryan(The University of Melbourne), Sally Bell(University of Glasgow), Mark Goodwin(Austin Health), Beng Ghee Lim(The Royal Melbourne Hospital), Ben Marginson(The Royal Melbourne Hospital), William Kemp(Monash University), James Burnes(Eastern Health), Alexander Thompson(The University of Melbourne), Paul Simkin(The Royal Melbourne Hospital), Wa Cheung(Alfred Health)
BMC Cancer
May 29, 2020
10.1186/s12885-020-06806-4
Cited by 13

Related Papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
|The Lancet|2023|514
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
|Hepatology|2010|409
Laparoscopic Adjustable Gastric Banding in Severely Obese Adolescents
|JAMA|2010|366
Longitudinal weight gain in women identified With polycystic ovary syndrome: Results of an observational study in young women
|Obesity|2013|349
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
|AIDS|2010|202